HK:6978 Stock Latest News
Company AnnouncementsImmunotech Biopharm Seeks HK$37 Million via Share Placement to Fund R&D4d ago6978
Company AnnouncementsImmunotech Biopharm Updates Commercialisation Timeline for Core Cell Therapy EAL®1M ago6978
Company AnnouncementsImmunotech Biopharm Narrows Interim Loss But Net Liabilities Deepen2M ago6978
Company AnnouncementsImmunotech Biopharm Sets August Board Meeting to Approve Interim Results2M ago6978
Company AnnouncementsImmunotech Biopharm Advances Liver Cancer Cell Therapies and Begins ATL Commercialization5M ago6978
Company AnnouncementsImmunotech Biopharm Shareholders Unanimously Back All AGM Resolutions6M ago6978Company AnnouncementsImmunotech Biopharm Halts Trading Pending Inside-Information Announcement6M ago6978
Company AnnouncementsImmunotech Biopharm Sets 2026 AGM With Share Mandate and Board Re-Elections on Agenda6M ago6978
Company AnnouncementsImmunotech Biopharm Brings Forward 2026 AGM and Adjusts Book Closure Dates6M ago6978
Company AnnouncementsImmunotech Biopharm Widens Annual Loss as Cancer Cell Therapies Advance in China7M ago6978
Company AnnouncementsImmunotech Biopharm Tightens Audit Committee Rules to Bolster Governance7M ago6978
Company AnnouncementsImmunotech Biopharm Updates Remuneration Committee Terms to Strengthen Governance7M ago6978Company AnnouncementsImmunotech Biopharm Sets March Board Meeting to Approve 2025 Annual Results7M ago6978
Company AnnouncementsImmunotech Biopharm Places RMB50 Million in EUR/USD-Linked Structured Deposit8M ago6978
- Company AnnouncementsImmunotech Biopharm Settles 2023 Bonds via RMB300 Million Convertible Issue8M ago6978
- Company AnnouncementsImmunotech Biopharm to Issue New Convertible Bonds to Settle 2023 Notes8M ago6978
- Company AnnouncementsImmunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly9M ago6978
- Company AnnouncementsImmunotech Biopharm Moves to Refinance 2023 Convertible Bonds via New Issue9M ago6978
Company AnnouncementsImmunotech Biopharm Ltd Engages in Strategic Financial Investment10M ago6978Company AnnouncementsImmunotech Biopharm Ltd’s Rights Issue Oversubscribed, Raising HK$257.29 Million11M ago6978